Tuesday, March 21, 2017

Imprimis Challenges Mallinckrodt's Acthar

Benzinga-6 hours ago
"It's apparent that efforts by policymakers to lower drug costs have been in vain," Imprimis said Tuesday. "It is only when there is competition or threats of ...
Post a Comment